Clinical Trial

T-cell Developmental Status in Patients With Malignant Hematological Tumors

Name: T-cell Developmental Status in Patients With Malignant Hematological Tumors — clinical trial record (NCT07035938)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the immune status and prognosis of patients with malignant hematological tumors, thereby guiding clinical therapeutic strategies.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-06-16; most recent amendment 2025-07-19.

Trial Details

NCT Number	NCT07035938
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	Hematologic Malignancy
Enrollment	75 participants
Start Date	2025-06-22
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-07-23